Pharmaceutical Development and Technology 2006-02-01

Adaptation of USP types II and IV controlled release assays for sparingly soluble compounds by direct eluent HPLC analysis.

P J Missel, L E Stevens

Index: Pharm. Dev. Technol. 11(1) , 87-91, (2006)

Full Text: HTML

Abstract

Measurement of drug release of a sparingly soluble drug by conventional methods proceeds very slowly without the aid of surfactants. Two preliminary automated methods were developed that increase sensitivity and accelerate such studies by working at very small reservoir volumes. All high pressure liquid chromatography (HPLC) equipment components were commercially available. Results are presented for the drug release of a single pellet of the sparingly soluble drug Eliprodil in two types of drug release experiments using (1) a stirred cell and (2) a flow-through method. Release rates measured from each method were comparable.


Related Compounds

Related Articles:

NMDA receptor antagonists do not block the development of sensitization of catalepsy, but make its expression state-dependent.

2001-04-01

[Behav. Pharmacol. 12(2) , 143-9, (2001)]

Synthesis and resolution of racemic eliprodil and evaluation of the enantiomers of eliprodil as NMDA receptor antagonists.

2000-06-19

[Bioorg. Med. Chem. Lett. 10(12) , 1377-80, (2000)]

The sequential analysis of repeated binary responses: a score test for the case of three time points.

2006-07-15

[Stat. Med. 25(13) , 2196-214, (2006)]

Human retina contains polyamine sensitive [3H]-ifenprodil binding sites: implications for neuroprotection?

1999-02-01

[Br. J. Ophthalmol. 83(2) , 236-40, (1999)]

Place conditioning of mice with the NMDA receptor antagonists, eliprodil and dizocilpine.

1998-12-04

[Eur. J. Pharmacol. 362(2-3) , 103-10, (1998)]

More Articles...